A5066288482- Fungal Infections and Studies
- Antifungal resistance and susceptibility
- Genetic factors in colorectal cancer
- Cancer-related gene regulation
- Helicobacter pylori-related gastroenterology studies
- Nail Diseases and Treatments
- Neutropenia and Cancer Infections
- Blood disorders and treatments
- Gastric Cancer Management and Outcomes
- Cancer-related Molecular Pathways
- Eosinophilic Disorders and Syndromes
- Gastrointestinal Tumor Research and Treatment
- Parathyroid Disorders and Treatments
- Pneumocystis jirovecii pneumonia detection and treatment
- Oral Health Pathology and Treatment
- Pancreatitis Pathology and Treatment
- Autoimmune Bullous Skin Diseases
- Colorectal Cancer Treatments and Studies
- Wnt/β-catenin signaling in development and cancer
- Viral-associated cancers and disorders
- Histiocytic Disorders and Treatments
- Chemotherapy-related skin toxicity
- Breast Cancer Treatment Studies
- Breast Lesions and Carcinomas
- Autoimmune and Inflammatory Disorders
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2001-2021
The progressive disseminated histoplasmosis (PDH) has been associated with severe disease and high risk of death among people living HIV (PLWHIV). Therefore, the purpose this multicenter, prospective, double-blinded study done in ten Mexican hospitals was to determine diagnostic accuracy detecting Histoplasma capsulatum antigen urine using IMMY ALPHA EIA kit (IAHE), clarus GM Enzyme Immunoassay (cHGEI IMMY) MiraVista Urine Antigen LFA (MVHUALFA); as well Hcp100 1281-1283220SCAR nested PCRs...
Background The Histoplasma urine antigen (HUAg) is the preferred method to diagnose progressive disseminated histoplasmosis (PDH) in HIV patients. In 2007, IMMY ALPHA EIA was approved for clinical on-site use, and therefore useful regions outside United States. However, ALPHA-HUAg considered inferior MVista-HUAg which only available on referral. We aim evaluate diagnostic accuracy of ALPHA-HUAg. Methodology/Principal findings conducted a multicenter, prospective, test study two secondary...
Background: Gastric carcinoma is characterised by numerous genetic and epigenetic alterations that influence cell cycle progression, apoptosis DNA repair. These include down-regulation of the cyclin-dependent kinase (CDK) inhibitors p21 WAF1/CIP1 p27 Kip1 , mutations tumour suppressor protein p53 adhesion molecule E-cadherin. Combined evaluation prognostic significance these has not been reported in Mexican Mestizo patients. Aims: To evaluate E-cadherin expression, including mutant variants...